Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Oct 25, 2021 9:31am
168 Views
Post# 34044127

Another Strong Week?

Another Strong Week?

Overall sentiment continues to be high on this Monday morning. The strongest support is at $.45 and the resistance levels are widening at $.51, $.545 and $.57 as Barchart issues a 56% BUY with a strengthening shorterm outlook. Morningstar's Fair Value sp has jumped to $.60 and their 1-star speculative valuation is moving toward $1.40.

In spite of some concern as to what a return to "normal" might look like, with most of the world yet to be vaccinated, with another potential Christmas lockdown for countries like the UK and many unvaccinated individuals within many other countries ....rapid antigen testing is not going anywhere soon. 

GLTE ...holding long ....it still seems our patience should be well rewarded as the last pieces for AcuVid fall into place.

<< Previous
Bullboard Posts
Next >>